Treatment at first relapse in multiple myeloma: how to choose a drug?
Frontline treatment of elderly multiple myeloma patients and management of relapse/refractory
Enrique Ocio et al.
Results of KEYNOTE-023 and pembrolizumab plus pomalidomide trials for multiple myeloma
Jesús San Miguel
Do Philadelphia chromosome-positive ALL patients need a stem cell transplant?
How new drugs may change the standard of care for CLL